Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Press Release

    Press Release - Page 20

    FDA approves Dupixent to treat Atopic Dermatitis

    FDA approves Dupixent to treat Atopic Dermatitis

    supriya kashyap kashyap30 March 2017 9:18 AM IST
    The U.S. Food and Drug Administration approved Dupixent (dupilumab) injection to treat adults with moderate-to-severe eczema (atopic dermatitis)....
    FDA approves maintenance treatment for recurrent epithelial ovarian, fallopian tube or primary peritoneal cancers

    FDA approves maintenance treatment for recurrent epithelial ovarian, fallopian tube or primary peritoneal cancers

    supriya kashyap kashyap28 March 2017 9:37 AM IST
    The U.S. Food and Drug Administration approved Zejula (niraparib) for the maintenance treatment (intended to delay cancer growth) of adult patients...
    Lupin receives FDA approval for generic TOBI inhalation solution

    Lupin receives FDA approval for generic TOBI inhalation solution

    supriya kashyap kashyap25 March 2017 10:59 AM IST
    Mumbai : Pharma Major Lupin Limited announced that it has received final approval for its Tobramycin Inhalation Solution USP, 300 mg/5 ml from the...
    FDA approves first treatment for rare form of skin cancer

    FDA approves first treatment for rare form of skin cancer

    supriya kashyap kashyap25 March 2017 10:24 AM IST
    The U.S. Food and Drug Administration granted accelerated approval to Bavencio (avelumab) for the treatment of adults and pediatric patients 12 years...
    Mylan Receives Tentative Approval for TLE400 Under PEPFAR

    Mylan Receives Tentative Approval for TLE400 Under PEPFAR

    supriya kashyap kashyap24 March 2017 10:11 AM IST
    England : Mylan N.V., a leading global pharmaceutical company, announced receipt of tentative approval from the U.S. Food and Drug Administration...
    FDA approves drug to treat Parkinson’s disease

    FDA approves drug to treat Parkinson’s disease

    supriya kashyap kashyap22 March 2017 11:12 AM IST
    The U.S. Food and Drug Administration today approved Xadago (safinamide) tablets as an add on treatment for patients with Parkinson’s disease who are...
    Heptares Therapeutics Enters Agreement With Daiichi Sankyo to Discover and Develop Novel, Small-molecules for the Treatment of Pain

    Heptares Therapeutics Enters Agreement With Daiichi Sankyo to Discover and Develop Novel, Small-molecules for the Treatment of Pain

    supriya kashyap kashyap21 March 2017 10:50 AM IST
    London : Heptares Therapeutics, a wholly owned subsidiary of Sosei Group Corporation announces that it has entered into a drug discovery and licensing...
    MedGenome announces the launch of Claria Carrier Screening Test

    MedGenome announces the launch of Claria Carrier Screening Test

    supriya kashyap kashyap20 March 2017 10:08 AM IST
    New Delhi : Every year, over a million babies are born in India with genetic disorders and 20 – 30% of infant mortality is due to these disorders. It...
    Stents under CGHS: Health Ministry

    Stents under CGHS: Health Ministry

    savita thakur thakur20 March 2017 10:08 AM IST
    CGHS does not procure and provide any stents to its beneficiaries directly and reimburses the cost of procedures at rates prescribed by CGHS to...
    POC Medical Systems unveils MammoAlert – A disruptive pre-screening test for early Breast Cancer Detection

    POC Medical Systems unveils MammoAlert – A disruptive pre-screening test for early Breast Cancer Detection

    supriya kashyap kashyap19 March 2017 11:12 AM IST
    Mumbai : POC Medical Systems Inc. unveiled a rapid, portable breast cancer screening test, MammoAlert™ based on its Pandora CDx™ microfluidics-based...
    Mylan Launches Generic Aromasin® Tablets

    Mylan Launches Generic Aromasin® Tablets

    supriya kashyap kashyap17 March 2017 11:52 AM IST
    England : Mylan N.V. announced the U.S. launch of Exemestane Tablets, 25 mg, a generic version of the reference listed drug, Pfizer's Aromasin®...
    Fujifilm India to install 1,000 Computer Radiography across India to improve healthcare infrastructure

    Fujifilm India to install 1,000 Computer Radiography across India to improve healthcare infrastructure

    supriya kashyap kashyap13 March 2017 12:00 PM IST
    Mumbai : Fujifilm India Private Ltd., a leader in medical equipments and devices to install 1,000 Computer Radiography across India with a commitment...
    PrevNext

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok